David Veillard

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Determinants of the experience of patients living with multiple sclerosis in terms of care pathway quality: An original French study.

Determinants of the experience of patients living with multiple sclerosis in terms of care pathway quality: An original French study.

Journal: Revue neurologique

Published: September 10, 2024

Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35).

Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35).

Journal: Multiple sclerosis and related disorders

Published: February 09, 2023

Dyadic coping strategies and quality of care experience: An original study of patients living with multiple sclerosis and their caregivers.

Dyadic coping strategies and quality of care experience: An original study of patients living with multiple sclerosis and their caregivers.

Journal: Revue neurologique

Published: October 27, 2022

Developing tools to evaluate quality of care management for patients living with multiple sclerosis: An original French initiative.

Developing tools to evaluate quality of care management for patients living with multiple sclerosis: An original French initiative.

Journal: Revue neurologique

Published: August 02, 2021

Geriatric Choosing Wisely choice of recommendations in France: a pragmatic approach based on clinical audits.

Geriatric Choosing Wisely choice of recommendations in France: a pragmatic approach based on clinical audits.

Journal: BMC geriatrics

Published: June 06, 2021

Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients.

Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients.

Journal: Revue neurologique

Published: May 31, 2021

Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.

Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.

Journal: Revue neurologique

Published: February 05, 2021

Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire.

Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire.

Journal: European journal of neurology

Published: October 12, 2020

COVID-19 Epidemic: Regional Organization Centered on Nursing Homes.

COVID-19 Epidemic: Regional Organization Centered on Nursing Homes.

Journal: Journal of the American Geriatrics Society

Published: April 30, 2020

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis.

Journal: Journal of neurology

Published: April 22, 2020

Organizational and managerial factors associated with clinical practice guideline adherence: a simulation-based study in 36 French hospital wards.

Organizational and managerial factors associated with clinical practice guideline adherence: a simulation-based study in 36 French hospital wards.

Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care

Published: February 29, 2016

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Journal: Lancet (London, England)

Published: July 03, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026